Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology
Abstract
Share and Cite
Cemin, R.; Casablanca, S.; Foco, L.; Schoepf, E.; Erlicher, A.; Di Gaetano, R.; Ermacora, D. Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology. J. Clin. Med. 2023, 12, 621. https://doi.org/10.3390/jcm12020621
Cemin R, Casablanca S, Foco L, Schoepf E, Erlicher A, Di Gaetano R, Ermacora D. Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology. Journal of Clinical Medicine. 2023; 12(2):621. https://doi.org/10.3390/jcm12020621
Chicago/Turabian StyleCemin, Roberto, Simona Casablanca, Luisa Foco, Elisabeth Schoepf, Andrea Erlicher, Renato Di Gaetano, and Davide Ermacora. 2023. "Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology" Journal of Clinical Medicine 12, no. 2: 621. https://doi.org/10.3390/jcm12020621
APA StyleCemin, R., Casablanca, S., Foco, L., Schoepf, E., Erlicher, A., Di Gaetano, R., & Ermacora, D. (2023). Reverse Remodeling and Functional Improvement of Left Ventricle in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan: Comparison between Non-Ischemic and Ischemic Etiology. Journal of Clinical Medicine, 12(2), 621. https://doi.org/10.3390/jcm12020621